Compare CNTA & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTA | SEMR |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 1.8B |
| IPO Year | 2021 | 2021 |
| Metric | CNTA | SEMR |
|---|---|---|
| Price | $22.78 | $11.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $38.00 | $12.75 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 11-05-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,000,000.00 | ★ $428,627,000.00 |
| Revenue This Year | N/A | $20.35 |
| Revenue Next Year | N/A | $14.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 118.88 | 19.87 |
| 52 Week Low | $9.60 | $6.56 |
| 52 Week High | $30.58 | $18.74 |
| Indicator | CNTA | SEMR |
|---|---|---|
| Relative Strength Index (RSI) | 39.86 | 75.84 |
| Support Level | $21.55 | $11.87 |
| Resistance Level | $22.47 | $11.94 |
| Average True Range (ATR) | 0.99 | 0.03 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 31.50 | 68.75 |
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.